• Empty Cart
    • عربي عربي
روشتة
  1. Home 1
  2. Medicines2
  3. sagitrixan 2.5 mg tablets2.5 mg3

sagitrixan 2.5 mg tablets

product image

  • Scientific Name: APIXABAN
  • Dosage: 2.5 mg
  • Type: Tablets

Price: 5.76 OMR | OMR


Buy the medicine
Saudi Arabia UAE Oman


    Medicine Description

    sagitrixan is used to treat blood clots and prevent pulmonary embolism. sagitrixan contains the active ingredient apixpan.




    latest articles

    • comparison of the difference between davalindi and ossofortin and their uses
    • claritine 10 tablets
    • Comparison of the difference between Plavex and Aspirin Protect tablets for the prevention of strokes
    • em ex 1ampoule 3 mg/3ml
    • Comparison of the difference between Celebrex and Ketofan tablets and which is better for pain relief
    • Comparison of the difference between Tareg and Co-Tareg for the treatment of high blood pressure




    Related medicines

    apixatrack 2.5 mg tablets 2.5 mg
    apixatrack 2.5 mg tablets 2.5 mg | Tablets
    pixaspire 2.5 mg tablets 2.5 mg
    pixaspire 2.5 mg tablets 2.5 mg | Tablets
    endlixaban 2.5mg tablets 2.5mg
    endlixaban 2.5mg tablets 2.5mg | Tablets
    apixatrack 2.5 mg tablets 2.5 mg
    apixatrack 2.5 mg tablets 2.5 mg | Tablets

    Latest medicines

    contafever n 120 ml oral suspension
    contafever n 120 ml oral suspension | Oral suspension
    cordo 60 ml spray
    cordo 60 ml spray | Spray
    colosalazine ec 500 mg 20 tablets 500 mg
    colosalazine ec 500 mg 20 tablets 500 mg | Tablets
    cough rest n 120 ml syrup
    cough rest n 120 ml syrup | Syrup
    Checkout
    Cart :

    Back

    Cart

    • About Us
    • Rosheta
    • Privacy Policy
    • terms of services
    • Gastrointestinal
    • Respiratory System
    • Articles
    • Medicines
    • General Medicine
    • Antodine
    • Controloc
    • Maxilase
    • Call Us

    © 2025 All Rights Reserved Rosheta - Developed By Rosheta

    Login Or Register

    Login Or Register

    By registering, you agree on Our terms & Conditions.